A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Clinical trial NCT04916002 · TERMINATED

Trial details

NCT number: NCT04916002
Sponsor: Regeneron Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Merkel Cell Carcinoma Cutaneous Squamous Cell Carcinoma Basal Cell Carcinoma Triple Negative Breast Cancer Non-Small Cell Lung Cancer Oropharynx Squamous Cell Carcinoma

Start date: 2021-11-30
Primary completion: 2024-10-31
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.